neoplasm
• smaller tumors of mice treated with piperlongumine than in Krastm3Tyj heterozygotes
|
• fewer tumors by 12 weeks with a more than 2-fold reduction in tumor burden compared with Krastm3Tyj heterozygotes
|
cellular
• in tumors of mice treated with piperlongumine
|
• increased compared with Krastm3Tyj heterozygotes
|
respiratory system
• fewer tumors by 12 weeks with a more than 2-fold reduction in tumor burden compared with Krastm3Tyj heterozygotes
|